Evidence map›Paper›PMID 32773033›Full record

ArticleeLife2020

Population-scale proteome variation in human induced pluripotent stem cells.

Bogdan Andrei Mirauta, Daniel D Seaton, Dalila Bensaddek, Alejandro Brenes, Marc Jan Bonder, Helena Kilpinen, HipSci Consortium, Oliver Stegle, Angus I Lamond

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Species-wide quantitative transcriptomes and proteomes reveal distinct genetic control of gene expression variation in yeast.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 5 countries.

Bogdan Andrei Mirauta *European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, United Kingdom.ORCID https://orcid.org/0000-0002-9733-292X
Daniel D Seaton *European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, United Kingdom.
Dalila Bensaddek *Centre for Gene Regulation & Expression, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Alejandro BrenesCentre for Gene Regulation & Expression, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Marc Jan BonderEuropean Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, United Kingdom.ORCID http://orcid.org/0000-0002-8431-3180
Helena KilpinenEuropean Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, United Kingdom.ORCID https://orcid.org/0000-0001-6692-6154
HipSci ConsortiumEuropean Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, United Kingdom.
Oliver Stegle *European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, United Kingdom.ORCID https://orcid.org/0000-0002-8818-7193
Angus I Lamond *Centre for Gene Regulation & Expression, School of Life Sciences, University of Dundee, Dundee, United Kingdom.ORCID https://orcid.org/0000-0001-6204-6045
University of Michigan · USEuropean Bioinformatics Institute · GBUniversity of Dundee · GB

Funding

EMBL Interdisciplinary Postdoctoral (EIPOD) programme under Marie Sklodowska-Curie Actions COFUND 291772Medical Research Council MR/L016311/1Wellcome TrustWellcome Trust Strategic Award 105024/Z/14/ZWellcome Trust Strategic Award and UK Medical Research Council WT098503
6 · The paper itself

Abstract

Human disease phenotypes are driven primarily by alterations in protein expression and/or function. To date, relatively little is known about the variability of the human proteome in populations and how this relates to variability in mRNA expression and to disease loci. Here, we present the first comprehensive proteomic analysis of human induced pluripotent stem cells (iPSC), a key cell type for disease modelling, analysing 202 iPSC lines derived from 151 donors, with integrated transcriptome and genomic sequence data from the same lines. We characterised the major genetic and non-genetic determinants of proteome variation across iPSC lines and assessed key regulatory mechanisms affecting variation in protein abundance. We identified 654 protein quantitative trait loci (pQTLs) in iPSCs, including disease-linked variants in protein-coding sequences and variants with

Indexed as

Genetic VariationProteomeTranscriptomeAdolescentAdultAgedChildChild, PreschoolDiseaseFemaleGenetics, PopulationGenotypeHumansInduced Pluripotent Stem CellsInfantInfant, NewbornProteomeRNA, Messengerdeleterious variantsgeneticsgenomicshumaninduced pluripotent stem cellsproteomics

Identifiers

PMID32773033
PMCPMC7447446
OpenAlexW3048820111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.